Sufentanil Citrate (Sufentanil Citrate) (Injection) 0.05 mg/mL

Sufentanil Citrate Injection 0.05 mg/mL is a potent opioid analgesic used for pain management in medical settings. This high-strength formulation provides rapid relief for severe pain. Ideal for controlled environments like hospitals and surgical suites.

Strength

0.05 mg/mL

Manufacturer / TM Owner

West-Ward Pharmaceuticals Corp.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sufentanil Citrate Injection is primarily used to manage severe pain during surgical procedures and in intensive care settings. It may also be used for anesthesia induction and maintenance in patients requiring significant pain control. This medication is intended for use by healthcare professionals in clinical environments where rapid and potent analgesia is required.

Side Effects

Sufentanil Citrate Injection typically produces rapid pain relief within minutes of administration. Patients may experience sedation and relaxation alongside pain reduction. The effects are dose-dependent, with higher doses providing more profound analgesia and sedation.

Precautions & Warnings

Sufentanil Citrate Injection should only be administered by trained medical professionals in a controlled setting. Patients must be closely monitored for respiratory depression and other opioid-related side effects. It is not intended for outpatient or home use due to its potency and potential risks.

Avoid Interactions

Concurrent use with other central nervous system depressants, such as benzodiazepines or alcohol, may increase the risk of respiratory depression and sedation. Sufentanil Citrate may interact with CYP3A4 inhibitors, potentially altering its metabolism. Always inform healthcare providers of all medications being taken.

Frequently Asked Questions

It is used for managing severe pain during surgical procedures and in intensive care settings.

Pain relief typically begins within minutes of administration.

No, it is intended for use by healthcare professionals in controlled clinical settings only.

Common effects include sedation, relaxation, and respiratory depression.

Yes, it may interact with other CNS depressants and CYP3A4 inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.